Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

3 Dec 2020 07:00

RNS Number : 3509H
MJ Gleeson PLC
03 December 2020
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, is holding its Annual General Meeting (AGM) at 11am today. Due to Covid-19 restrictions, the AGM will be a closed meeting and held with the minimum required quorum present.

Dermot Gleeson, Chairman, will make the following comments:

"Build and sales activity at Gleeson Homes has returned to pre-Covid levels. We are grateful to the Government for implementing measures that ensured we could return to sites safely and securely following the first national lockdown and continue to deliver much-needed affordable homes. During the second lockdown all our sites continued to build and sell efficiently within Covid-secure protocols. We expect this to continue in the newly established three-tier system of restrictions.

Demand for Gleeson's low-cost homes remains strong and selling prices continue to increase. The average selling price on new reservations since the start of the financial year has been 9% higher than in the same period last year.

Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a land pipeline of 13,938 plots with a gross development value of £2.0 billion, of which 7,298 plots are owned and 6,640 are conditionally purchased.

The division currently has 80 active build sites, compared with 64 active build sites this time last year. We have opened 11 new build sites since the start of the financial year. We expect to open at least another 14 new build sites before the end of the financial year. The division currently has 65 active sales sites, similar to the 64 sales sites this time last year, but we expect to be actively selling on all our current build sites before the end of the financial year.

The Board expects Gleeson Homes to record an increase in sales revenue for the half year to 31 December 2020 of more than 15% compared with the same period last year.

Record new site openings, strong demand driven by the structural need for low-cost quality homes for first-time buyers and our ability to offer attractive levels of affordability to our customers, mean that the outlook for the division remains very positive. As a result, the Board now expects Gleeson Homes' results for the year to exceed current expectations. The Board re-affirms its target of delivering 2,000 units per annum in the year to June 2022.

Gleeson Strategic Land has seen activity continue to pick up since the start of the current financial year.

The division's land pipeline currently consists of 72 sites which have the potential to deliver approximately 23,560 plots. The portfolio includes 12 sites which now have planning permission.

Importantly, the division is actively working on the sale of seven sites. Most of these transactions are at an advanced stage. This level of activity underpins our confidence that the full year outturn in Gleeson Strategic Land will be in line with expectations.

Overall, driven by the strong performance in Gleeson Homes and the encouraging level of activity in Gleeson Strategic Land, the Board now expects the Group to deliver a result for the full year ahead of current expectations.

The Board recognises the importance of dividend payments to shareholders. In the light of our strong performance to date and the positive outlook, the Board is minded to resume dividend payments during the course of 2021. However, any final decision will depend on the circumstances at the time."

 

3 December 2020

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

 

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

 

Stefan Allanson

Chief Financial Officer

 

 

 

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

 

Rosie Driscoll

 

 

 

N+1 Singer

 

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

 

 

 

Liberum

 

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZMGZRZGGGZM
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.